FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for Pantoprazole sodium from Mylan Pharmaceuticals Inc., continuing approval for this generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erosive Esophagitis
• Gastroesophageal Reflux Disease
• Hypersecretory States
• Peptic Ulcer Disease
• Zollinger-ellison Syndrome

Drugs mentioned

• Pantoprazole sodium (pantoprazole sodium)

Snippet

SUPPL AP for PANTOPRAZOLE SODIUM (PANTOPRAZOLE SODIUM)